Candidate Markers Associated with the Probability of Future Pulmonary Exacerbations in Cystic Fibrosis Patients

Ozone Is Associated With an Increased Risk of Respiratory Exacerbations in Patients With Cystic Fibrosis

(2013) Sylvia C.L. Farhat et al.   CHEST

Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: The early intervention in cystic fibrosis exacerbation (eICE) trial

(2013) N. Lechtzin et al.   Contemporary Clinical Trials

Peroxidized unsaturated fatty acids stimulate Toll-like receptor 4 signaling in endothelial cells

(2013) Akiko Mutoh et al.   LIFE SCIENCES

Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation

(2013) Alex R Horsley et al.   THORAX

Anti-inflammatory effects of tobramycin and a copper-tobramycin complex with superoxide dismutase-like activity

(2012) M Gziut et al.   BRITISH JOURNAL OF PHARMACOLOGY

A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended care

(2012) Gregory S. Sawicki et al.   PEDIATRIC PULMONOLOGY

The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations

(2012) Anthony A. Fodor et al.   PLoS One

Sputum Biomarkers and the Prediction of Clinical Outcomes in Patients with Cystic Fibrosis

(2012) Theodore G. Liou et al.   PLoS One

Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients

(2012) Rogier A. S. Hoek et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis

(2012) Iara Maria Sequeiros et al.   Chronic Respiratory Disease

Extending the course of intravenous antibiotics in adult patients with cystic fibrosis with acute pulmonary exacerbations

(2012) Iara Maria Sequeiros et al.   Chronic Respiratory Disease

Incidence and Risk Factors for Pulmonary Exacerbation Treatment Failures in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa

(2011) Michael D. Parkins et al.   CHEST

Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis

(2011) Valerie Waters et al.   EUROPEAN RESPIRATORY JOURNAL

Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis

(2011) K. de Boer et al.   THORAX

Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation

(2010) Don B. Sanders et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Eicosapentaenoic acid modulates neutrophil leukotriene B4 receptor expression in cystic fibrosis

(2010) R. H. LAWRENCE et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Sputum and serum calprotectin are useful biomarkers during CF exacerbation

(2010) R.D. Gray et al.   Journal of Cystic Fibrosis

Increased lipid peroxidation and abnormal fatty acid profiles in seminal and blood plasma of normozoospermic males from infertile couples

(2009) I. Oborna et al.   HUMAN REPRODUCTION

Cystic Fibrosis Fatty Acid Imbalance Is Linked to Ceramide Deficiency and Corrected by Fenretinide

(2008) Claudine Guilbault et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Lipoxin A4 and interleukin-8 levels in cystic fibrosis sputum after antibiotherapy

(2008) Raphaël Chiron et al.   Journal of Cystic Fibrosis